Clinical Trials Browser

Phase 1 × Hereditary Sensory and Autonomic Neuropathies × serabelisib × Clear all

NCT01449370 2017-03-09

Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced Cancer

Phase 1 Completed

125 enrolled 46 charts

Neoplasms, Hereditary Sensory and Autonomic Neuropathies